Song et al.’s [126,127] research in 2010 demonstrated that in a rat model of early liver cancer induced by cyclophosphamide, AST effectively reduced the number and size of liver cancer lesions by regulating the Nrf2/ARE pathway. The gene discussed is NFE2L2; the disease is liver cancer.